Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
RVMD:NASDAQ
Revolution Medicines Inc
$135.30
+0.61%
(+0.82) 1D
$135.30
0.00% (0.00)
After hours
Closed: Apr 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RVMD...
Open
$134.58
High
$138.44
Low
$132.00
Mkt. cap
28.30B
Avg. vol.
3.14M
Volume
3.50M
52-wk high
$155.70
52-wk low
$34.00
EPS
-$5.95
Beta
1.01
Shares outstanding
208.74M
No. of employees
883
News stories
From sources across the web
About Revolution Medicines Inc
CEO-
Employees883
Founded2014
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websiterevmed.com
Next call in 11 days
Wed, May 6, 4:30 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-1.84 est.)USD
Revenue / Estimate
-/ (2.42M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
205.75M
19.13M
262.51M
294.94M
Cost of revenue
205.75M
19.13M
262.51M
294.94M
Research and development expenses
-
205.01M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.01M
40.58M
52.76M
66.68M
Operating expense
35.01M
245.59M
52.76M
66.68M
Total operating expenses
240.76M
264.71M
315.27M
361.63M
Operating income
-240.76M
-264.71M
-315.27M
-361.63M
Other non operating income
2.43M
-5.48M
-592.00K
-12.62M
EBT including unusual items
-213.42M
-247.79M
-305.21M
-364.89M
EBT excluding unusual items
-213.42M
-247.79M
-305.21M
-364.89M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-213.42M
-247.79M
-305.21M
-364.89M
Net profit margin
-
-
-
-
Earnings per share
-1.13
-1.31
-1.61
-1.86
Interest and investment income
24.92M
22.40M
22.08M
21.29M
Interest expense
-
-
-11.43M
-11.94M
Net interest expenses
24.92M
22.40M
10.66M
9.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-239.10M
-262.89M
-313.24M
-359.39M
Gain or loss from assets sale
-
-
32.00K
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more